Correction: RPL28 mediates sorafenib resistance in hepatocellular carcinoma by downregulating CDC6 expression

Frontiers in Oncology 2026 Open access

Read full text
Authors: Yi Shi, Fangfang Chen, Yuanyuan Weng, Hang Zeng, Gang Chen
DOI: 10.3389/fonc.2026.1814738
Cited by: 0

Abstract

[This corrects the article DOI: 10.3389/fonc.2026.1741406.].

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Cancer-related Molecular Pathways Drug Transport and Resistance Mechanisms

Publication details

Journal / source
Frontiers in Oncology
Volume
16
Pages
1814738–1814738
Publication date
4 March 2026
Language
EN